
Marko Nikolic
Articles
-
Nov 30, 2024 |
nature.com | Joshua Rosenheim |Claire Broderick |Loukas Papargyris |Andrew Kwok |Helen R. Wagstaffe |Emily Conibear | +15 more
AbstractBlood transcriptional biomarkers of acute viral infections typically reflect type 1 interferon (IFN) signalling, but it is not known whether there are biological differences in their regulation that can be leveraged for distinct translational applications. We use high frequency sampling in the SARS-CoV-2 human challenge model to show induction of IFN-stimulated gene (ISG) expression with different temporal and cellular profiles.
-
Sep 30, 2024 |
geneticliteracyproject.org | Kaylee B. Worlock |Marko Nikolic
Throughout the pandemic, one of the key questions on everyone’s mind was why some people avoided getting COVID, while others caught the virus multiple times.
-
Aug 15, 2024 |
goodgoodgood.co | Marko Nikolic
Throughout the pandemic, one of the key questions on everyone’s mind was why some people avoided getting COVID, while others caught the virus multiple times.
Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature
Aug 1, 2024 |
nature.com | Kaylee B. Worlock |Lisa M Dratva |Masahiro Yoshida |Helen R. Wagstaffe |Laura Richardson |Josephine Barnes | +25 more
Correction to: Nature https://doi.org/10.1038/s41586-024-07575-x Published online 19 June 2024In the version of the article initially published, the Acknowledgements was missing the following text, which has now been added to the HTML and PDF versions of the article: “The authors gratefully acknowledge support from the UK Vaccine Taskforce of the Department of Business, Energy and Industrial Strategy of Her Majesty’s Government (BEIS).
-
Jul 16, 2024 |
scroll.in | Marko Nikolic
Throughout the pandemic, one of the key questions on everyone’s mind was why some people avoided getting Covid-19, while others caught the virus multiple times.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →